Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide combinations for use in the diagnosis of schizophrenia

Peptide combinations for use in the diagnosis of schizophrenia

US Patent 11385242 · Granted Jul 12, 2022

Estimated economic value: $58,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodul2015
Cyclic phosphates as plant growth regulators2012
Assay for the diagnosis of schizophrenia based on a new peptide2006
Skin test for schizophrenia2006
Pharmaceutical compositions comprising cyclic glycerophosphates and analogs ther2005
Cyclic glycerophosphates and analogs thereof2005
Insect trap2003
Preparations for the treatment of T cell mediated diseases2002
Method for the treatment of cancer using phosphatidic acid-comprising compositio2002
Lipid-based immune modulator composition2001
Phosphatidic acid-comprising compositions2000
Diagnosis of the susceptibility of contracting schizophrenia1999